Literature DB >> 24725488

Decision making and prostate cancer screening.

Sara J Knight1.   

Abstract

This article presents an overview of the challenges that men encounter in making decisions about prostate cancer screening, including complex affective and cognitive factors and controversies in the interpretation of the evidence on prostate cancer screening. Shared decision making involving patient decision aids are discussed as approaches that can be used to improve the quality of prostate cancer screening decisions, including a close alignment between a man's values, goals, and preferences and his choice about screening. Published by Elsevier Inc.

Entities:  

Keywords:  Informed decision making; Patient decision aid; Patient preferences; Patient values; Prostate cancer screening; Prostate specific antigen (PSA) test; Shared decision making; Values clarification

Mesh:

Year:  2014        PMID: 24725488     DOI: 10.1016/j.ucl.2014.01.008

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  8 in total

1.  Prostate cancer screening: going beyond the clinical evidence.

Authors:  Murray Krahn
Journal:  CMAJ       Date:  2014-10-27       Impact factor: 8.262

2.  Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.

Authors:  Jun Li; Ingrid J Hall; Guixiang Zhao
Journal:  Cancer Causes Control       Date:  2017-02-16       Impact factor: 2.506

3.  Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.

Authors:  Guan Xu; Mandy C Davis; Javed Siddiqui; Scott A Tomlins; Shengsong Huang; Lakshmi P Kunju; John T Wei; Xueding Wang
Journal:  Biomed Opt Express       Date:  2015-11-09       Impact factor: 3.732

4.  Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.

Authors:  Michael A Diefenbach; Catherine Benedict; Suzanne M Miller; Annette L Stanton; Mary E Ropka; Kuang-Yi Wen; Linda G Fleisher; Nihal E Mohamed; Simon J Hall
Journal:  Transl Behav Med       Date:  2018-11-21       Impact factor: 3.046

5.  The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD).

Authors:  Shiyong Xin; Xianchao Sun; Liang Jin; Weiyi Li; Xiang Liu; Liqing Zhou; Lin Ye
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

6.  Impact of numeracy on understanding of prostate cancer risk reduction in PSA screening.

Authors:  Kevin Koo; Charles D Brackett; Ellen H Eisenberg; Kelly A Kieffer; Elias S Hyams
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

7.  The Relation among Prostate Cancer Knowledge and Psychosocial Factors for Prostate Cancer Screening among African American Men: a Correlational Study.

Authors:  Sabrina L Dickey; Aurellia Whitmore; Ellen Campbell
Journal:  AIMS Public Health       Date:  2017-10-25

8.  Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.

Authors:  Ying-Li Lin; Pei-Gen Xie; Li Wang; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.